02.28.24 -- Why Is Clinical Finance Important?

Choosing the right clinical packaging and supply chain partner to support APAC studies can vary significantly based upon which countries are involved and the types of services required.

The industry is measuring longer cycle times between protocol approval and site activation. Experts from Novartis and IQVIA share creative solutions to combat this trend and accelerate trial timelines.

Learn why it’s important to build strong relationships with opinion leaders in the healthcare industry, as well as how to establish and maintain those relationships successfully.

Join global logistics leaders for an in-depth analysis of the evolving pharmaceutical supply chain, exploring critical issues, emerging trends, and strategies for navigating the complexities of 2024.

Get acquainted with IRT in areas such as no-code study deployment, automated excursion reviews, rapid prototyping, AI-enabled data sets, reduced (or removed) change orders, and more.

Explore the benefits of a late-stage customization (LSC) approach, including how it can support a leaner, more responsive supply chain, ensuring life-changing therapies reach patients more efficiently.

New studies estimate DCTs deliver more than a five-fold return on investment due to reductions in clinical phase cycle times, decreases in screen failure rates, and fewer protocol amendments.

Delve into the advantages and disadvantages of patient-centric and patient-led trials, how technology can help bring patient equity, and what the future holds for patient partnerships.

Understand why efficient ePRO solutions are essential in measuring patients' perception of their symptoms and quality of life in ophthalmology research.